Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DX25F6ACC
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $131,266
Award facts
- Contract value 100% obligated
- $131,266.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $131,266.40 by the Defense Logistics Agency's Medical Supply Chain division on July 28, 2025. The delivery order, set to be completed by August 18, 2025, covers the supply of Keytruda 100 mg/4 ml vials to support Department of Defense healthcare facilities. This award was issued without a set-aside designation, demonstrating the contractor's competitive capability in federal pharmaceutical procurement. The order represents a specific drawdown against DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at approximately $500 million through November 2026.
As a critical supplier within the federal pharmaceutical distribution network, DMS Pharmaceutical Group specializes in providing branded and generic prescription drugs, biologics, and medical consumables to military health facilities nationwide. The company's contract portfolio reflects its expertise in delivering specialty pharmaceutical products, including oncology treatments, vaccines, and other critical medications essential to Department of Defense healthcare operations. This delivery order for Keytruda, an oncology therapeutic, aligns with the contractor's established track record of supplying specialized pharmaceutical products to support the medical readiness and healthcare requirements of the military health system.
Quick answers
Who was awarded contract SPE2DX25F6ACC?
SPE2DX25F6ACC was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on July 28, 2025.
How much is contract SPE2DX25F6ACC worth?
The government has obligated $131,266 on SPE2DX25F6ACC.
Is contract SPE2DX25F6ACC an order under another contract?
Yes. SPE2DX25F6ACC is a delivery order under SPE2DX15D9114, an indefinite delivery contract.
Was contract SPE2DX25F6ACC competed?
The extent of competition for SPE2DX25F6ACC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award